Log in to your Inderes Free account to see all free content on this page.
Mendus
4.21 SEK
+1.45 %
Less than 1K followers
IMMU
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Mendus
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| EBITDA | -22.7 | -34.7 | -130.7 | -30.2 | -24.1 | -18.9 | ||
| EBIT | -22.7 | -34.7 | -130.7 | -30.2 | -24.1 | -20.4 | -38.7 | -113.5 |
| EBIT-% | ||||||||
| Profit before taxes | -23.0 | -31.5 | -128.4 | -30.5 | -22.7 | -19.0 | -41.1 | -113.3 |
| Net income | -23.0 | -31.5 | -128.4 | -30.5 | -22.7 | -19.0 | -41.1 | -113.3 |
Login required
This content is only available for logged in users